News Room

Press Releases

Mar 212015

NHSi Closes 2015 Financing

March 21st, 2015|

New Health Sciences has closed an additional $6.0 million Series B financing raised from existing private investors. NHSi will use the new capital to fund continued development of its Hemanext technology and to support an

Jan 52015

NHSi Hires VP, Research and Clinical Affairs

January 5th, 2015|

New Health Sciences has hired Andrew Dunham, PhD as Chief Scientific Officer / Vice President, Research and Clinical Affairs. Prior to joining NHSi, Dr. Dunham held researcher and senior positions at both specialty chemical and

Jul 72014

NHSi Hires VP, Product Development

July 7th, 2014|

New Health Sciences has hired Rafael Cordero as Vice President, Product Development. He will have responsibility for all product and process engineering as well as manufacturing and supply chain development. Mr. Cordero has over 25

Dec 102013

NHSi Closes Financing

December 10th, 2013|

New Health Sciences has closed a $6.0 million Series B financing raised from private investors. NHSi will use the new capital to fund continued development of its Hemanext technology.

Jul 12012

NHSi Closes Financing

July 1st, 2012|

New Health Sciences has closed a $4.0 million Series A financing raised from existing private investors. NHSi will use the new capital to fund continued development of its Hemanext technology.

Jul 222011

NHSi Closes Financing

July 22nd, 2011|

New Health Sciences has closed a $2.5 million Series A financing raised from existing private investors. NHSi will use the new capital to fund continued development of its Hemanext technology.